 |
Beyond the Drip PodcastWelcome to Beyond the Drip Podcast!Join us as we explore the world of Infusion Pharmacy, including Home Infusion and Ambulatory Infusion Centers. Featuring interviews with industry trailblazers, this podcast is your go-to source for the latest news,... Author: Prochant Language: en Genres: Business News, News Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Beyond the Drip: Site of Care, Payer Pressure, and The Future of Infusion Economics with idara Umoh
Episode 15
Saturday, 28 February, 2026
Welcome to Beyond the Drip, where we dive into the fascinating world of Infusion Pharmacy, from Home Infusion Therapy (HIT) to Ambulatory Infusion Centers (AICs) and Infusion Suites (AIS). Expect topical conversations on the latest happenings in Infusion from industry leaders who will bring you the latest news, trends and innovations in the infusion industry, as well as expert insights and stories to keep you informed and inspired. In this episode of Beyond the Drip, we sit down with Idara Umoh, founder of Echelon Health Partners, to pull back the curtain on the "hidden" economics of the infusion industry. With nearly 30 years of experience—from the halls of government policy to the front lines of health systems—Idara brings a perspective that most leaders miss.We move past the buzzwords to talk about the real-world pressure of market saturation and why chasing "scale" can sometimes be the very thing that breaks an operational core. If you've felt the squeeze of shrinking margins or the weight of vertical integration, this conversation is for you. We’re breaking down:The Private Equity Trap: Why growing too fast can lead to "operational fragility" and how to protect your mission while you scale.The Revenue Mirage: Why traditional KPIs might be lying to you about your actual financial health.Cash is King: The critical shift from tracking revenue to managing cash velocity and net margins.The Patient Advantage: Why human-centric care isn't just "nice to have"—it’s your best defense against competitor erosion.Whether you’re a clinician, an owner, or an investor, Idara’s insights will help you spot the warning signs before they become crises. This isn’t just a market update; it’s a survival guide for thriving in the future of infusion.
